OR WAIT 15 SECS
© 2020 MJH Life Sciences and Applied Clinical Trials Online. All rights reserved.
© 2020 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
February 10, 2020
Using venture philanthropy to get promising drug candidates past “the valley of death”-and supported by advanced scientific technology-rare disease patient organizations have moved beyond being just hopeful influencers, to now becoming powerful forces for change.
September 30, 2019
A recent survey shows that 40% of pediatric trials conducted between 2008 and 2011 were never finished or published. One of the main challenges is the need to collect multiple sequential blood samples. Which, mircosampling, could be the answer to.
July 31, 2019
Chris Barker, an Independent Statistical Consultant, discusses the differences and biases in summaries obtained from a database called PDQ vs. CTG.
June 18, 2019
How to account and adjust for covariates in clinical trial randomization-and be confident about uncertainty.
December 18, 2018
Using data analytics to introduce parallel processes to optimize and accelerate clinical trials.
July 01, 2018
Exploring that pivotal question for clinical investigators, sponsors, and global CROs.
June 14, 2018
Certified principal investigator certification as a predictor of major and critical protocol deviations in clinical trials.
May 04, 2018
There are several pharmacokinetic factors and peculiarities that should be considered carefully when designing and running first-in-human (FIH) studies for monoclonal antibodies.
April 05, 2018
Cancer immunotherapies require different standards for evaluating their safety and effectiveness. Understanding these standards-and the other major challenges of immuno-oncology studies-is critical to drug development success.
March 09, 2018
With technology’s increasing ability to gather and analyze previously unmanageable data sets, and medicine’s forays into genomics and targeted therapies, the time of the master protocol may be at hand.